Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lymphoseek vs. Sulfur Colloid for Lymphatic Mapping in Breast Cancer
NCT02287675Phase 4Completed
- Sponsor
- Kettering Health
- Start
- Jan 2015
- Primary completion
- Jan 2017
- Modality
- Radiopharmaceutical, Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of technetium tc 99m tilmanocept in breast cancer, sponsored by Kettering Health. Started Jan 2015; status: completed.
02
Drugs
technetium tc 99m tilmanocept
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02287675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02287675.